These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23301006)

  • 1. Oral anticoagulation therapy in heart failure patients in sinus rhythm: a systematic review and meta-analysis.
    Rengo G; Pagano G; Squizzato A; Moja L; Femminella GD; de Lucia C; Komici K; Parisi V; Savarese G; Ferrara N; Perrone-Filardi P; Leosco D
    PLoS One; 2013; 8(1):e52952. PubMed ID: 23301006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.
    Shantsila E; Lip GY
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD003333. PubMed ID: 27629776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation versus placebo for heart failure in sinus rhythm.
    Shantsila E; Kozieł M; Lip GY
    Cochrane Database Syst Rev; 2021 May; 5(5):CD003336. PubMed ID: 34002371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review.
    Lip GY; Gibbs CR
    QJM; 2002 Jul; 95(7):461-8. PubMed ID: 12096151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Net clinical benefit of antithrombotic therapy in patients with heart failure and sinus rhythm: A network meta-analysis from 5 clinical trials.
    Zhang C; Wang N; Shen NN; Kong LC; He J; Wu Y; Feng D; Gu ZC
    Thromb Res; 2020 Jun; 190():122-128. PubMed ID: 32361051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation versus placebo for heart failure in sinus rhythm.
    Lip GY; Wrigley BJ; Pisters R
    Cochrane Database Syst Rev; 2012 Jun; (6):CD003336. PubMed ID: 22696335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.
    Lip GY; Piotrponikowski P; Andreotti F; Anker SD; Filippatos G; Homma S; Morais J; Pullicino P; Rasmussen LH; Marín F; Lane DA;
    Thromb Haemost; 2012 Dec; 108(6):1009-22. PubMed ID: 23093044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of warfarin vs. antiplatelet therapy in patients with systolic heart failure and sinus rhythm: a systematic review and meta-analysis of randomized controlled trials.
    Liew AY; Eikelboom JW; Connolly SJ; O' Donnell M; Hart RG
    Int J Stroke; 2014 Feb; 9(2):199-206. PubMed ID: 23506160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation versus placebo for heart failure in sinus rhythm.
    Lip GY; Shantsila E
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD003336. PubMed ID: 24683002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of anticoagulation, antiplatelet, and placebo treatment for patients with heart failure reduced ejection fraction in sinus rhythm: a systematic review and meta-analysis.
    Sulaica EM; Macaulay TE; Helbing RR; Abo-Aly M; Abdel-Latif A; Wanat MA
    Heart Fail Rev; 2020 Mar; 25(2):207-216. PubMed ID: 31256317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-benefit profile of warfarin versus aspirin in patients with heart failure and sinus rhythm: a meta-analysis.
    Lee M; Saver JL; Hong KS; Wu HC; Ovbiagele B
    Circ Heart Fail; 2013 Mar; 6(2):287-92. PubMed ID: 23264446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm.
    Lip GY; Gibbs CR
    Cochrane Database Syst Rev; 2001; (4):CD003333. PubMed ID: 11687189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral anticoagulation versus antiplatelet or placebo for stroke prevention in patients with heart failure and sinus rhythm: Systematic review and meta-analysis of randomized controlled trials.
    Ntaios G; Vemmos K; Lip GY
    Int J Stroke; 2019 Dec; 14(9):856-861. PubMed ID: 31526132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.
    Lip GY; Ponikowski P; Andreotti F; Anker SD; Filippatos G; Homma S; Morais J; Pullicino P; Rasmussen LH; Marin F; Lane DA;
    Eur J Heart Fail; 2012 Jul; 14(7):681-95. PubMed ID: 22611046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of vitamin-K antagonists and direct oral anticoagulants for stroke prevention in patients with heart failure and sinus rhythm: An updated systematic review and meta-analysis of randomized clinical trials.
    Li W; Seo J; Kokkinidis DG; Palaiodimos L; Nagraj S; Korompoki E; Milionis H; Doehner W; Lip GYH; Ntaios G
    Int J Stroke; 2023 Apr; 18(4):392-399. PubMed ID: 35689348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S; Trappolini M; Chillotti FM
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet and anticoagulant agents in heart failure: current status and future perspectives.
    Gurbel PA; Tantry US
    JACC Heart Fail; 2014 Feb; 2(1):1-14. PubMed ID: 24622113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics.
    Massie BM; Krol WF; Ammon SE; Armstrong PW; Cleland JG; Collins JF; Ezekowitz M; Jafri SM; O'Connor CM; Packer M; Schulman KA; Teo K; Warren S
    J Card Fail; 2004 Apr; 10(2):101-12. PubMed ID: 15101020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials.
    Kumar S; Danik SB; Altman RK; Barrett CD; Lip GY; Chatterjee S; Roubin GS; Natale A; Danik JS
    Cardiol Rev; 2016; 24(5):218-23. PubMed ID: 26274538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet agents and anticoagulants for hypertension.
    Lip GY; Felmeden DC
    Cochrane Database Syst Rev; 2004; (3):CD003186. PubMed ID: 15266473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.